• Preliminary findings from ongoing Phase I trial of second-generation DMT asset SPL028 indicate the potential for a unique therapeutic profile ...
Discover the psychedelic wonders of the B+ mushroom in our detailed guide. Learn about their potency and dosage and how to identify them in the wild.
This is the FDA’s first guidance focusing on psychedelic drug development. Phillips Lytle law firm takes a closer look. The post FDA Draft Guidance on...
Public comment on the draft proposal will be collected for the next 60 days. The post FDA Issues Draft Guidance on Clinical Trials for Psychedelic Drugs...
Key companies covered in cannabidiol (CBD) market are Medical Marijuana Inc. (California, U.S.), Cannoid, LLC (Colorado, U.S), Isodiol International Inc....
Discover the psychedelic wonders of the Cambodian mushroom in our detailed guide. Learn about their potency and dosage and how to identify them in the...
The FDA has published new guidance for researchers investigating the use of psychedelic drugs for the treatment of medical conditions. The post FDA Issues...
In clinical settings, a racemic mixture of both R and S ketamine is commonly used The post PharmaTher Holdings enters collaboration to commercialize racemic...
Discover the psychedelic wonders of the Teonanacatl mushroom in our detailed guide. Learn about their potency and dosage and how to identify them in the...
The experiential training will only be available through Numinus and will utilize the protocol of MAPS The post Optimi Health to supply MDMA for new psychedelic...